| Literature DB >> 32706334 |
Alexandre Carayon1,2,3, Laetitia Bataillé1,2,3, Gaëlle Lebreton1,2,3, Laurence Dubois1,2,3, Aurore Pelletier1,2,3, Yannick Carrier1,2,3, Antoine Wystrach2,3, Alain Vincent1,2,3, Jean-Louis Frendo1,2,3.
Abstract
Myogenesis is an evolutionarily conserved process. Little known, however, is how the morphology of each muscle is determined, such that movements relying upon contraction of many muscles are both precise and coordinated. Each Drosophila larval muscle is a single multinucleated fibre whose morphology reflects expression of distinctive identity Transcription Factors (iTFs). By deleting transcription cis-regulatory modules of one iTF, Collier, we generated viable muscle identity mutants, allowing live imaging and locomotion assays. We show that both selection of muscle attachment sites and muscle/muscle matching is intrinsic to muscle identity and requires transcriptional reprogramming of syncytial nuclei. Live-imaging shows that the staggered muscle pattern involves attraction to tendon cells and heterotypic muscle-muscle adhesion. Unbalance leads to formation of branched muscles, and this correlates with locomotor behavior deficit. Thus, engineering Drosophila muscle identity mutants allows to investigate, in vivo, physiological and mechanical properties of abnormal muscles.Entities:
Keywords: D. melanogaster; developmental biology; muscle identity; myology; transcription factors
Mesh:
Substances:
Year: 2020 PMID: 32706334 PMCID: PMC7431191 DOI: 10.7554/eLife.57547
Source DB: PubMed Journal: Elife ISSN: 2050-084X Impact factor: 8.140
Figure 1.Col CRMs, CRM deletions and col transcription.
(A) Diagrammatic representation of the sequential emergence of 4 different PCs from the Col-expressing PMC (grey), division of the DA3/DO5 PC into 2 FCs and col auto-regulation in the DA3 lineage; the names of each PC and FC are indicated. Accumulation of Col protein is in green. The time windows of mesodermal early (E-CRM) and late (L-CRM) CRM activity are indicated by green lines. Right: muscle pattern of an abdominal segment highlighting DA2 (orange) and DA3 (green). (B) Schematic representation of the col transcribed region (http://flybase.org/cgi-bin/gbrowse2/dmel/?Search=1;name=FBgn0001319). The position of tested GMR and VT fragments are drawn as brown horizontal bars; the numbers are given for those active in DA3. The positions of clusters of in vivo Mef-2, Twi and Tin binding sites are indicated by vertical blue bars, the kn transposon insertion, used for the E-CRM deletion screening, by a vertical arrow. (C) Enlarged view of L-CRM indicating the juxtaposition of PC-specific and autoregulatory DA3-specific CRMs, Col, Mef2 and Twi binding sites, and the col and col deletions generated by CRISPR/cas9 genome editing. (D) Col transcription in wt and mutant embryos, genotypes indicated, visualised by in situ hybridisation to primary transcripts. A detail of the abdominal A2 segment (squared area) is shown in each panel. PMC col transcription is lost in colE embryos; stage 11, col transcription in the DA3/DO5 and DT1/DO4 PCs is detected in all strains; stage 14, DA3 syncytium transcription is lost in col and col embryos. * indicates col transcription in a multidendritic neuron (md).
Genomic sequence spanning the previously mapped E-CRM (start and end indicated in red) and the col deleted fragment (dashed blue line). The nucleotide positions of the col deletion endpoints (brown) are given relative to the col transcription start site. The predicted cleavage sites of the used sgRNAs (sequences underlined) are indicated by yellow arrows. The MiMIC 15480 used for the screening of the deletion is inserted between the red underlined nucleotides. Predicted binding sites for Twist (blue) and Mef2 (purple), conserved between Drosophila species.
Genomic sequence spanning the col (from −2666 to −1339) and col (from −1857 to −1339) deletions. Deleted fragments are represented by dashed lines and their coordinates given relative to col transcription start site. The predicted cleavage sites of the used sgRNAs (sequences underlined) are indicated by yellow arrows. Predicted binding sites for Twist (blue), Mef2 (purple), and Col (green), conserved between Drosophila species.
(A) Schematic representation of col L-CRM (see also Figure 1) indicating the positions of the −2.3 to −1.6 fragment (grey) previously shown to drive expression in the DA3 syncytium and new reporter constructs, −3.3–2.3 and −3.3–2.3 ΔMT with the position of conserved Mef2 and Twi binding sites. (B) Nucleotide sequence of the −3.3–2.3 fragment, positions −3385 to −2273. The >20 bp sequence motifs that are more than 90% conserved at the same relative positions in D. melanogaster, D. pseudobscura and D. virilis are shaded in grey. The 97 bp segment containing both Mef2 (purple) and Twi (blue) binding and deleted in 3.3–2.3ΔMT is underlined. (C) In situ hybridisation to primary reporter transcripts (yellow intron (yi) inserted in the lacZ coding sequence). The 3.3–2.3 fragment drives specific expression in the DA3/DO5 and DT1/DO4 PCs (circled in segment T2 and framed in A2) and the intercalary segment (arrow). Its activity in PCs is lost upon deletion of the region encompassing Mef2 and Twi binding sites (3.3–2.3ΔMT reporter).
Figure 1—figure supplement 1.Genomic sequence of the E-CRM deletion.
Genomic sequence spanning the previously mapped E-CRM (start and end indicated in red) and the col deleted fragment (dashed blue line). The nucleotide positions of the col deletion endpoints (brown) are given relative to the col transcription start site. The predicted cleavage sites of the used sgRNAs (sequences underlined) are indicated by yellow arrows. The MiMIC 15480 used for the screening of the deletion is inserted between the red underlined nucleotides. Predicted binding sites for Twist (blue) and Mef2 (purple), conserved between Drosophila species.
Figure 1—figure supplement 2.Genomic sequence of the L-CRM deletions.
Genomic sequence spanning the col (from −2666 to −1339) and col (from −1857 to −1339) deletions. Deleted fragments are represented by dashed lines and their coordinates given relative to col transcription start site. The predicted cleavage sites of the used sgRNAs (sequences underlined) are indicated by yellow arrows. Predicted binding sites for Twist (blue), Mef2 (purple), and Col (green), conserved between Drosophila species.
Figure 1—figure supplement 3.Mapping of a PC-specific CRM.
(A) Schematic representation of col L-CRM (see also Figure 1) indicating the positions of the −2.3 to −1.6 fragment (grey) previously shown to drive expression in the DA3 syncytium and new reporter constructs, −3.3–2.3 and −3.3–2.3 ΔMT with the position of conserved Mef2 and Twi binding sites. (B) Nucleotide sequence of the −3.3–2.3 fragment, positions −3385 to −2273. The >20 bp sequence motifs that are more than 90% conserved at the same relative positions in D. melanogaster, D. pseudobscura and D. virilis are shaded in grey. The 97 bp segment containing both Mef2 (purple) and Twi (blue) binding and deleted in 3.3–2.3ΔMT is underlined. (C) In situ hybridisation to primary reporter transcripts (yellow intron (yi) inserted in the lacZ coding sequence). The 3.3–2.3 fragment drives specific expression in the DA3/DO5 and DT1/DO4 PCs (circled in segment T2 and framed in A2) and the intercalary segment (arrow). Its activity in PCs is lost upon deletion of the region encompassing Mef2 and Twi binding sites (3.3–2.3ΔMT reporter).
Figure 2.DA3 muscle transformations upon col-CRM deletions.
(A) L-CRM-moeGFP expression in stage 11 and 15 hemizygous embryos, as indicated. GFP expression in PCs at stage 11 is similar in all strains. DA3>DA2 transformations (arrow) and branched DA3 muscles (arrowhead) are observed in col embryos. (B) Quantification of the relative proportions of normal DA3, branched DA3, DA3>DA2 transformation and absence of DA3 muscles in wt, col, col and col hemizygous embryos. A minimum of 100 A1-A7 abdominal segments of stage 15–16 embryos were analysed for each genotype. (+/Df: n = 127 segments - 16 embryos; col/Df: n = 170 segments - 23 embryos; col/Df: n = 190 segments - 27 embryos; col/Df: n = 103 segments - 13 embryos).
Figure 3.Identity reprogramming of syncytial nuclei controls the final muscle morphology.
(A) Col immunostaining of wt, col and col embryos, showing a normal pattern at stage 11 and complete absence of Col protein at stage 15 in both col embryos. (B) Stage14 embryos with a close up view of 4 segments shows low amounts of Col protein (black arrow) in the growing DA3 muscle in col and absence in col embryos (white arrow). Position of the multidendritic neuron (md) is indicated. (C) Col transcription (red dots), Col protein (blue) and L-CRM-moeGFP expression (green) in the DA3/DO5 PC, stage 11, DA3 FC, stage 12, and developing DA3 muscle, stage 14, in wt/Df, col and col; L-CRM-moeGFP embryos. In each panel, col transcripts are shown separately in black and white. col transcription ceases after FC stage in col embryos and does not propagate to other syncytial nuclei in col embryos. (D) Quantification of col primary transcripts level in PC and FC nuclei; orange asterisk: col transcription in FCs is generally lost in col embryos; quantification was done on a small fraction of FCs; n: number of PC or FC analysed, using 5 or six embryos at each stage 11 and 12; 15 col embryos were used for the FC stage (Mean ± sem and ***: p<0.001). (E) Schematic representation of the dynamics of col transcription (red dots) and Col protein (green) in the DA3/DO5 PC, the DA3 FC, muscle precursor, and DA3, DA3>DA2 and branched DA3 muscles in wt, col and col embryos, respectively. Temporal activity of E-CRM and L-CRM is represented by horizontal grey bars.
At stage 15, dots corresponding to col transcription are detected in syncytial DA3 nuclei in wt and col embryos. At stage 16, col transcription is no more detected neither in control nor in L-CRM deletions, except in multidendritic (md) ddaC neurons, indicated by an arrow.
(A) DA3 col (green) and nau (red) transcription dots at the PC and FC stage. Nuclei are labelled by Mef2 immunostaining (blue) and ROIs (regions of interest) used for quantification are circled. One col and two nau dots are observed in heterozygous (wt/Df, col and col) embryos. (B) Calculated dot intensity ratios (mean intensity) between the FC and PC stages. Number of nuclei used to calculate the mean dot intensity: nau: wt PC n = 28, FC n = 19; col PC n = 24, FC n = 26; col PC n = 25, FC n = 18; for col: wt PC n = 19, FC n = 28; col PC n = 26, FC n = 25; col PC n = 18, FC n = 24. nau data indicate a slight decrease between the PC and FC stages in all three conditions. col data show increased transcription between the PC and FC stage in wt embryos.
Figure 3—figure supplement 1.Col transcription in col and col embryos In situ hybridisation to col primary transcripts in stage 15 and 16 wt/Df, col and col embryos.
At stage 15, dots corresponding to col transcription are detected in syncytial DA3 nuclei in wt and col embryos. At stage 16, col transcription is no more detected neither in control nor in L-CRM deletions, except in multidendritic (md) ddaC neurons, indicated by an arrow.
Figure 3—figure supplement 2.Nau expression is not affected in col and col embryos.
(A) DA3 col (green) and nau (red) transcription dots at the PC and FC stage. Nuclei are labelled by Mef2 immunostaining (blue) and ROIs (regions of interest) used for quantification are circled. One col and two nau dots are observed in heterozygous (wt/Df, col and col) embryos. (B) Calculated dot intensity ratios (mean intensity) between the FC and PC stages. Number of nuclei used to calculate the mean dot intensity: nau: wt PC n = 28, FC n = 19; col PC n = 24, FC n = 26; col PC n = 25, FC n = 18; for col: wt PC n = 19, FC n = 28; col PC n = 26, FC n = 25; col PC n = 18, FC n = 24. nau data indicate a slight decrease between the PC and FC stages in all three conditions. col data show increased transcription between the PC and FC stage in wt embryos.
Figure 4.Multistep muscle attachment to selected tendon cells.
(A) F-actin (green) and Ilk-GFP (red) staining of stage 17 control and col embryos, showing heterotypic and homotypic muscle attachment sites, respectively. A drawing illustrates muscle matching in control embryos and mismatching in col embryos, with DA1, DA2 and DA3 muscles coloured in blue, yellow and green, respectively and attachment sites as red lines. (B) Snapshots of live imaging DA3 muscle development, using L-CRM-moeGFP expression (green). Tendon cell precursors express stripe-Gal4; UAS-RFP (red). Embryos were filmed during 4 hr (Sup. Videos 1 and 2) and Z sections collected every ~2–2.5 min. The outlines of the developing muscles are schematised for each stage. In both control (left, one segment shown) and col embryos (right, two segments shown), the posterior muscle end reaches the intersegmental border first. At stage 14, wt DA3 contacts both dorsal and lateral tendon cells at its anterior end. In col embryos, the anterior dorsal projections fail to retract, leading to ectopic DA3>DA2 attachment and branched muscles.
Video 1.Live-imaging of wt embryos.
The DA3 muscle is visualised by L-CRM-moeGFP (green) and tendon cell along the entire intersegmental border by stripe Gal4;UASmCD8RFP (red). Embryos were filmed during 4 hr. See also the legend of Figure 4.
Video 2.Live-imaging of col embryos.
The DA3 muscle is visualised by L-CRM-moeGFP (green) and tendon cell along the entire intersegmental border by stripe Gal4;UASmCD8RFP (red). Embryos were filmed during 4 hr. See also the legend of Figure 4.
Figure 5—figure supplement 1.Identification of a vg CRM active in the DA2 and DA3 muscles.
(A) Schematic representation of the vestigial (vg) transcribed region (https://flybase.org/cgi-bin/gbrowse2/dmel/?Search=1;name=FBgn0003975). GMR fragments tested for their enhancer activity are drawn as brown horizontal bars; GMR69G04 and GMR69G05 are active in DA3 and DA2 muscles. The fragment of overlap between GMR69G04 and GMR69G05, positions 12889557–12891520 on Chr2R, is called vgM1 (B) vgM1-moeGFP expression in the DA2, DA3 and VL1 muscles in wild type embryos at stages 14 and 16 (schematised on the right); higher magnification views show the close apposition of the DA3 ventral and DA2 dorsal sufaces at stage 14 and their tandem arrangement at stage 16. Of note, vgM1 expression seems to be more robust in DA2 than DA3.
Figure 5.DA3 heterotypic and homotypic muscle attachment sites (iMAS) in wt and L-CRM mutants.
(A) Immunostaining of wt and col VgM1-moeGFP-H2bRFP; srGal4 >mcd8 RFP; L-CRM-moeGFP embryos for GFP (green), RFP (red) and Spectrin (blue). DA3 (DA3>DA2) and DA2 muscles are indicated in each panel. At stage 14, the wt DA3 and col DA3>DA2 attachment sites partly align over the intersegmental border (circled). Their dorsal surface closely contacts DA2 via numerous protrusions; at stage 15, likely because homotypic DA3/DA3 and DA2/DA2 repulsion, these protrusions are restricted away from intersegmental borders in wt embryos while maintained in col. At stage 16, stable heterotypic DA3/DA2 contacts in wt, and both homotypic DA3>DA2/DA3>DA2 and DA3>DA2/DA2 contacts are stabilised. Anti-Spectrin staining is shown in black and white on the right of each panel, to indicate the position of the dorsal iMASs. (B) Schematic drawings of DA muscle development (green) in wt and colembryos; interpreted from data in Figure 4 and supplementary videos. Arrows indicate attractive cues, broken lines repulsive cues, thin circles attachment initiation, thick circles, attachment stabilisation. DA3 MAS initiation starts earlier at its posterior than anterior end. Homotypic repulsion between muscles of same identity leads to DA3 posterior attachment to lateral tendon cells. Repulsion does not operate upon DA3>DA2 transformation, leading to stable homotypic DA3>DA2 and DA3>DA2/DA2 iMASs.
(A) Schematic representation of the vestigial (vg) transcribed region (https://flybase.org/cgi-bin/gbrowse2/dmel/?Search=1;name=FBgn0003975). GMR fragments tested for their enhancer activity are drawn as brown horizontal bars; GMR69G04 and GMR69G05 are active in DA3 and DA2 muscles. The fragment of overlap between GMR69G04 and GMR69G05, positions 12889557–12891520 on Chr2R, is called vgM1 (B) vgM1-moeGFP expression in the DA2, DA3 and VL1 muscles in wild type embryos at stages 14 and 16 (schematised on the right); higher magnification views show the close apposition of the DA3 ventral and DA2 dorsal sufaces at stage 14 and their tandem arrangement at stage 16. Of note, vgM1 expression seems to be more robust in DA2 than DA3.
Only the GFP channel is shown, in black and white, to highlight protrusions emanating from the DA3 and DA2 muscles which contact each other (white arrows). Similar protrusions are seen between the DA2 and DA1 muscle (open arrows) which expresses VgM1-moeGFP in the thoracic T2 muscle (blue open arrows). The DA3/DA2 and DA2/DA1 muscle-muscle attachments are circled in white at one segment boundary. The observed protrusions are very dynamic as observed in videos and schematised in Figure 5B.
Figure 5—figure supplement 2.Interactions between the developing DA2 and DA3 muscles via dynamic protrusions Immunostaining of a stage 15 VgM1-moeGFP-H2bRFP; srGal4 >mcd8 RFP; L-CRM-moeGFP embryo.
Only the GFP channel is shown, in black and white, to highlight protrusions emanating from the DA3 and DA2 muscles which contact each other (white arrows). Similar protrusions are seen between the DA2 and DA1 muscle (open arrows) which expresses VgM1-moeGFP in the thoracic T2 muscle (blue open arrows). The DA3/DA2 and DA2/DA1 muscle-muscle attachments are circled in white at one segment boundary. The observed protrusions are very dynamic as observed in videos and schematised in Figure 5B.
Figure 6.Muscle mismatching in L-CRM mutant larvae.
(A) Mhc-GFP expression in control, col and col live 3rd instar larvae; lateral views, anterior to the left. Examples of DA3, DA3>DA2 and DA3 branched muscles are circled in white. (B) Quantification of the relative proportions of DA3, branched DA3, DA3>DA2 and absence of DA3 muscles in A1 to A7 segments of wt/Df, col/Df and col/Df; Mhc-GFP larvae; (wt/Df, n = 375 segments/27 larvae; col/Df, n = 320/23; col/Df, n = 264/19). (C) Scanning electron microscopy of filleted larvae showing the dorsal and dorso-lateral muscles, schematically colour-coded below. In wt larvae, the DA muscles are parallel to each other within a segment with precise matching of the DA3/DA2 and DA2/DA1 MASs at each posterior segmental border. In col larvae, DA3>DA2 muscles show homotypic, dorsal MASs and the DA3/LL1 connection is lost. The posterior MASs of branched DA3 is composite.
The dorsal midline is represented by a yellow dashed line. Upper panels: four abdominal segments of wt and col L3 larvae. Lower panels: muscle orientations are schematised by coloured lines, DA1 blue, DA2 yellow, DA3 green, LL1 red and SBM grey. In a wild type larva, the DA1, DA2 and DA3 muscles are oriented parallel and draw a force line over three consecutive segments and straight tension lines between two adjacent segments. In col larvae, DA3>DA2 and branched DA3 transformations these lines are broken due to the formation of homotypic DA3>DA2 MAS and either loss or reduction of the DA3/LL1 connection.
Figure 6—figure supplement 1.Scanning electron microscopy of wt and col internal muscles Larval fillets cut longitudinally along the ventral midline to expose the dorsal and dorso-lateral internal muscles.
The dorsal midline is represented by a yellow dashed line. Upper panels: four abdominal segments of wt and col L3 larvae. Lower panels: muscle orientations are schematised by coloured lines, DA1 blue, DA2 yellow, DA3 green, LL1 red and SBM grey. In a wild type larva, the DA1, DA2 and DA3 muscles are oriented parallel and draw a force line over three consecutive segments and straight tension lines between two adjacent segments. In col larvae, DA3>DA2 and branched DA3 transformations these lines are broken due to the formation of homotypic DA3>DA2 MAS and either loss or reduction of the DA3/LL1 connection.
Figure 7.Branched muscles result in specific locomotion defects.
(A) Left, Tukey’s diagrams (box-plot graph) showing the walking rate in mm/s (crawling speed) of wt/Df (n = 118), col (n = 108) and col/Df (n = 112) larvae. Each point represents the average measurement for one larva, recorded during 20 s. 50% of points are located within the Tukey’s diagram. The red line gives the median, the narrowed area, the confidence interval of the median (95%). Right, same data as left, showing the mean speed ± standard error of mean (SEM) for each genotypes. (B) Stride length in mm. (C) Stride duration in s. The number of larvae (n) tested for each genotype is indicated in (A). Only significant differences are indicated (*p<0.05 and **p<0.01).
Phalloidin and anti-HRP staining of wt and col 3rd instar larval fillets, showing internal DA muscles (green) and intersegmental nerve (ISN) projections (white), schematically colour-coded below. ISN projection to the DA3 muscle is circled by a red dashed line. Absence of projection is indicated by a red cross.
Figure 7—figure supplement 1.DA muscles innervation in L-CRM mutant larvae.
Phalloidin and anti-HRP staining of wt and col 3rd instar larval fillets, showing internal DA muscles (green) and intersegmental nerve (ISN) projections (white), schematically colour-coded below. ISN projection to the DA3 muscle is circled by a red dashed line. Absence of projection is indicated by a red cross.
Author response image 1.LacZ immunostaining of stage 14 embryos, carrying a late col CRM reporter (p2.
6-0.9LacZ). Left: The Col binding site is intact. LacZ expression is predominantly detected in the DA3 muscle. Right: The Col binding site is mutated (nucleotides in red). Low level of LacZ expression is detected in the DA3 as well as DT1, DO5 and LL1 muscles.
Author response image 2.
Author response image 3.| Reagent type | Designation | Source or | Identifiers | Additional |
|---|---|---|---|---|
| Strain, strain background ( | white[1118] | Bloomington | BDSC Cat# 3605, RRID: | |
| Strain, strain background ( | Df(2L)BSC429 | Bloomington | BDSC Cat# 24933, RRID: | |
| Strain, strain background ( | vasa-cas9VK00027 | Bloomington | BDSC Cat# 51324, RRID: | |
| Strain, strain background ( | sr-Gal4 | obtained from G. Morata, Madrid, Spain | ||
| Strain, strain background ( | Col1 | Our lab | ||
| Strain, strain background ( | Mi{MIC}knMI15480/SM6a | Bloomington | BDSC Cat# 67516, RRID: | MiMic Line |
| Strain, strain background ( | GMR69G03 | Bloomington | BDSC Cat# 39500, RRID: | GMR line, GMR located in the Vg gene |
| Strain, strain background ( | GMR69G04 | Bloomington | #46616 | GMR line, GMR in the Vg gene |
| Strain, strain background ( | GMR69G05 | Bloomington | #39501 | GMR line, GMR in the Vg gene |
| Strain, strain background ( | GMR69G06 | Bloomington | #39502 | GMR line, GMR in the Vg gene |
| Strain, strain background ( | GMR69G07 | Bloomington | BDSC Cat# 47956, RRID: | GMR line, GMR in the Vg gene |
| Strain, strain background ( | GMR69G08 | Bloomington | BDSC Cat# 46617, RRID: | GMR line, GMR in the Vg gene |
| Strain, strain background ( | GMR69G09 | Bloomington | BDSC Cat# 46618 | GMR line, GMR in the Vg gene |
| Strain, strain background ( | GMR69G10 | Bloomington | BDSC Cat# 39503 | GMR line, GMR in the Vg gene |
| Strain, strain background ( | GMR69G12 | Bloomington | BDSC Cat# 46619 | GMR line, GMR in the Vg gene |
| Strain, strain background ( | GMR69G03 | Bloomington | BDSC Cat# 46620, RRID: | GMR line, GMR in the Vg gene |
| Strain, strain background ( | GMR12A09 | Bloomington | BDSC Cat# 47319 | GMR line, GMR in the Kn gene |
| Strain, strain background ( | GMR12G07 | Bloomington | BDSC Cat# 47854, RRID: | GMR line, GMR in the Kn gene |
| Strain, strain background ( | GMR12H01 | Bloomington | BDSC Cat# 48528, RRID: | GMR line, GMR in the Kn gene |
| Strain, strain background ( | GMR13A11 | Bloomington | BDSC Cat# 49248 | GMR line, GMR in the Kn gene |
| Strain, strain background ( | GMR13B06 | Bloomington | BDSC Cat# 48544, RRID: | GMR line, GMR in the Kn gene |
| Strain, strain background ( | GMR13B08 | Bloomington | BDSC Cat# 48546, RRID: | GMR line, GMR in the Kn gene |
| Strain, strain background ( | GMR13C09 | Bloomington | BDSC Cat# 48555, RRID: | GMR line, GMR in the Kn gene |
| Strain, strain background ( | GMR13C11 | Bloomington | BDSC Cat# 48556, RRID: | GMR line, GMR in the Kn gene |
| Strain, strain background ( | GMR13F08 | Bloomington | BDSC Cat# 48576, RRID: | GMR line, GMR in the Kn gene |
| Strain, strain background ( | GMR13F10 | Bloomington | BDSC Cat# 48578, RRID: | GMR line, GMR in the Kn gene |
| Strain, strain background ( | GMR47D05 | Bloomington | BDSC Cat# 47605, RRID: | GMR line, GMR in the Kn gene |
| Strain, strain background ( | GMR46H09 | Bloomington | BDSC Cat# 54712, RRID: | GMR line, GMR in the Kn gene |
| Antibody | anti-col (Mouse monoclonal) | Our lab | 1:50 | |
| Antibody | anti-LacZ (Mouse monoclonal) | Promega | Promega Cat# Z3781, RRID: | 1:1000 |
| Antibody | anti-spectrin (Mouse monoclonal) | Hybridoma Bank | DSHB Cat# 3A9 (323 or M10-2), RRID: | 1:200 |
| Antibody | anti-GFP (Rabbit polyclonal) | Biolabs | Torrey Pines Biolabs Cat# TP401 071519, RRID: | 1:1000 |
| Antibody | anti-GFP (Chicken polyclonal) | Abcam | Abcam Cat# ab13970, RRID: | 1:500 |
| Antibody | Phalloidin-texas red | Thermofisher Scientific | Cat# Cat#T7471 | 1:500 |
| Antibody | Alexa fluor antibodies 488, 555 and 647 | Molecular probes | 1:300 | |
| Antibody | Alexa fluor 594 anti HRP | Jackson Immunological research | Jackson ImmunoResearch Labs Cat# 123-585-021, RRID: | 1:300 |
| Antibody | Alexa fluor phalloidin | Thermofisher Scientific | Thermo Fisher Scientific Cat# A12381, RRID: | 1:500 |
| Antibody | Biotinylated goat anti-mouse | Vector Laboratories | Vector Laboratories Cat# BA-9200, RRID: | 1:2000 |
| Software, algorithm | ImageJ | ImageJ, RRID: | ||
| Software, algorithm | FIMTrack | |||
| Software, algorithm | MATLAB | MathWorks | MATLAB, RRID: | |
| Other | FISH probes labelled with Quasar dye 670 (col) | Biosearch Technologies and this study | Kn first intron | |
| Other | FISH probes labelled with Quasar dye 570 (nau) | Biosearch Technologies and this study | Nau first and third introns |